MARYJANE EASLEY: Open Payments
NPI 1073829982 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 21 payments from 19 companies in 2025. Trend: 2023 $345 · 2024 $429 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Menarini Silicon Biosystems, Inc. | 1 | $34 |
| ABBVIE INC. | 2 | $33 |
| Janssen Biotech, Inc. | 1 | $29 |
| ACCORD HEALTHCARE, INC. | 1 | $28 |
| Alexion Pharmaceuticals, Inc. | 1 | $28 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Incyte Corporation | 1 | $27 |
| Stemline Therapeutics Inc. | 1 | $26 |
| GENZYME CORPORATION | 1 | $25 |
Products named: Cellsearch, RYBREVANT, Camcevi, ULTOMIRIS, GIVLAARI, JAKAFI, Orserdu, FRUZAQLA.
Industry payments across OK — which companies pay providers there.
